--------------------
human
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
AVGs
AVFs
https://cdt.amegroups.com/article/view/10.21037/cdt-21-523/rc
--------------------
continue
AVGs
AVFs
Thrombectomy
rheolytic
AVGs
AVFs
--------------------
create
Thrombosed
AVGs
AVFs
Thrombectomy
rheolytic
AVGs
AVFs
AVGs
AVFs
--------------------
explain
AVGs
AVFs
--------------------
human
disease-2019
78%.5
CSDH)8
--------------------
continue
--------------------
explain
--------------------
create
disease-2019
--------------------
human
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
CD203a
ADPR
CD73
eADO
CD73
TNAP
eAMP
eADO
REF].Analogous
eATP
eADO
eADO
--------------------
explain
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
eADO
eATP
eADO
CD39
CD73
eAMP
eATP
eATP
eADO
CD203a
eAMP
eADO
eADO
eADO
eADO
CD73
--------------------
create
adenosinergic
eADO
eATP
eATP
eADO
immunosurveillance
eATP
eADO
eATP
eADO
eATP
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
--------------------
continue
adenosinergic
adenosinergic
eATP
eADO
eATP
eATP
eATP
eADO
ectonucleotidases
CD39
CD73
eATP
eADO
eADO
eADO
adenosinergic
adenosinergic
eATP
eADO
adenosinergic
eATP
adenosinergic
adenosinergic
eATP
eADO
adenosinergic
--------------------
human
REF]).Detailed
sarcopenic
sarcopenic
sarcopenic
--------------------
continue
AgeiNg
ENHANce
sarcopenic
SarQoL
SarQoL
--------------------
create
Jentoft
Jentoft
AgeiNg
ENHANce
--------------------
explain
sarcopenic
sarcopenic
--------------------
create
--------------------
human
PASC.The
https://recovercovid.org/protocols
PASC.The
--------------------
explain
--------------------
continue
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
AVGs
AVFs
https://cdt.amegroups.com/article/view/10.21037/cdt-21-523/rc
AVGs
AVFs
rheolytic
Thrombectomy
AVGs
AVFs
rheolytic
AVGs
AVFs
hemoconcentration
Thrombosed
Thrombectomy
Thrombectomy
AVGs
AVFs
disease-2019
78%.5
CSDH)8
disease-2019
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
CD203a
ADPR
CD73
eADO
CD73
TNAP
eAMP
eADO
REF].Analogous
eATP
eADO
eADO
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
eADO
eATP
eADO
CD39
CD73
eAMP
eATP
eATP
eADO
CD203a
eAMP
eADO
eADO
eADO
eADO
CD73
adenosinergic
eADO
eATP
eATP
eADO
immunosurveillance
eATP
eADO
eATP
eADO
eATP
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
eATP
eADO
eATP
eATP
eATP
eADO
ectonucleotidases
CD39
CD73
eATP
eADO
eADO
eADO
adenosinergic
adenosinergic
eATP
eADO
adenosinergic
eATP
adenosinergic
adenosinergic
eATP
eADO
adenosinergic
REF]).Detailed
sarcopenic
sarcopenic
sarcopenic
EWGSOP2
AgeiNg
ENHANce
sarcopenic
SarQoL
SarQoL
Jentoft
Jentoft
AgeiNg
ENHANce
sarcopenic
sarcopenic
PASC.The
https://recovercovid.org/protocols
PASC.The
